AST Clinical Services Launches eCRFast®

Share Article

AST’s innovative electronic data capture (EDC) solution has passed extensive clinical trials, and is poised to help the clinical research industry with their data management needs.

Ultimately, eCRFast allowed us to clean your data faster, lock your database faster and lower your costs.

AST Clinical Services, a leading multi-services contract research organization, today announced the launch of eCRFast®, its electronic data capture (EDC) solution. This achievement will help the company provide the pharmaceutical industry and CROs with a state-of-the-art, cost-effective, CDISC and 21 CFR part 11 compliant EDC solution.

“eCRFast® was developed in close partnership with end-users, and is based on the latest security and coding technologies to improve the user experience and decrease the learning curve,” said Joseph-Carl Theodat, VP of the Solutions division. “Usability and user-friendliness are key to the success of eCRFast® and this is why it has satisfied the most rigorous user acceptability testing.”

President Alain-Steve Theodat said that the development of eCRFast® was a “significant milestone” for AST Clinical Services.

“We are very pleased that our testers have recognized the value of eCRFast® and our commitment to providing the best EDC alternative to our clients. This recognition will motivate us to continue giving our clients unsurpassed services and the best solutions on the market,” he said.

AST Clinical Services has been providing clinical research solutions since 2005. The company is known for the quality of its project management, clinical monitoring and consulting services.

“AST Clinical Services is in a great position to implement eCRFast® in our current activities. We are definitely on our way to achieving partnerships with major clients,” said Carlot Junior Theodat, Executive Vice President, Sales & Alliances of the Solutions division.

AST Clinical Solutions, a division of AST Clinical Services, is a testament to the collaborative work of scientists in the Services division and IT specialists in the Solutions division.

“Their efforts demonstrate the value of networked R&D, which accelerates drug development and enables affordable technology solutions worldwide,” added Carlot Junior Theodat.

For more information about eCRFast®, please visit


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Alain-Steve Theodat
Visit website